In the second quarter of 2025, the apixaban price index in the United States indicated levels of 44,617 USD/MT by June. The index movement highlighted steady growth, supported by rising consumption in cardiovascular and stroke prevention medications across the healthcare sector. https://www.imarcgroup.com/apixaban-pricing-report